Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 2:05 pm Unchanged | 13G | Calidi Biotherapeutics Inc. CLDI | Polar Asset Management Partners Inc. | 0 0.000% | 0 (Unchanged) | View |
| 2024-09-11 4:04 pm Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | Funicular Funds LP | 897,241 9.990% | 897,241 (New Position) | View |
| 2024-02-14 4:02 pm Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | 683 Capital Management LLC | 675,758 1.900% | 375,758 (+125.25%) | View |
| 2024-02-14 06:05 am Sale | 13G | Calidi Biotherapeutics Inc. CLDI | First Light Acquisition Group LLC | 343,687 11.000% | -2,232,116 (-86.66%) | View |
| 2024-02-12 5:32 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | First Trust Capital Management L.P. | 0 0.000% | -400,000 (Position Closed) | View |
| 2024-02-12 4:33 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | Woodline Partners LP | 125,000 0.400% | -275,000 (-68.75%) | View |
| 2024-02-09 5:03 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | SPRING CREEK CAPITAL LLC | 0 0.000% | -356,098 (Position Closed) | View |
| 2024-02-09 06:53 am Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | Polar Asset Management Partners Inc. | 2,290,086 6.100% | 1,877,286 (+454.77%) | View |
| 2023-10-10 1:58 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | Hudson Bay Capital Management LP | 0 0.000% | -500,000 (Position Closed) | View |
| 2023-09-29 6:51 pm Purchase | 13D | Calidi Biotherapeutics Inc. CLDI | Jackson Investment Group LLC | 3,287,788 9.100% | 3,287,788 (New Position) | View |
| 2023-09-25 6:46 pm Purchase | 13D | Calidi Biotherapeutics Inc. CLDI | Leftwich Scott | 3,394,545 13.000% | 3,394,545 (New Position) | View |
| 2023-09-25 6:46 pm Purchase | 13D | Calidi Biotherapeutics Inc. CLDI | Camaisa Allan | 12,037,296 30.900% | 12,037,296 (New Position) | View |
| 2023-09-08 4:07 pm Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | Funicular Funds LP | 716,315 17.400% | 716,315 (New Position) | View |
| 2023-09-08 2:48 pm Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | METEORA CAPITAL LLC | 612,856 14.850% | 612,856 (New Position) | View |
| 2023-06-27 6:07 pm Purchase | 13D | Calidi Biotherapeutics Inc. CLDI | Jackson Investment Group LLC | 705,987 14.600% | 255,987 (+56.89%) | View |
| 2023-02-14 2:09 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | 683 Capital Management LLC | 300,000 7.300% | -900,000 (-75.00%) | View |
| 2023-02-14 12:26 pm Purchase | 13G | Calidi Biotherapeutics Inc. CLDI | First Trust Capital Management L.P. | 400,000 9.690% | 400,000 (New Position) | View |
| 2023-02-13 11:23 am Sale | 13G | Calidi Biotherapeutics Inc. CLDI | Beryl Capital Management LLC | 0 0.000% | -1,159,998 (Position Closed) | View |
| 2023-02-10 5:23 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | First Light Acquisition Group LLC | 2,575,803 38.400% | -2,029,947 (-44.07%) | View |
| 2023-02-10 4:08 pm Sale | 13G | Calidi Biotherapeutics Inc. CLDI | Woodline Partners LP | 400,000 9.700% | -1,580,000 (-79.80%) | View |